California State Teachers Retirement System (CalSTRS)
FDMT icon

California State Teachers Retirement System (CalSTRS)’s 4D Molecular Therapeutics FDMT Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.25K Sell
620
-1,809
-74% -$17.6K ﹤0.01% 2365
2026
Q1 		$22.6K Sell
2,429
-42
-2% -$366 ﹤0.01% 2397
2025
Q4 		$18.5K Sell
2,471
-30
-1% -$304 ﹤0.01% 2547
2025
Q3 		$21.7K Buy
+2,501
New +$14.9K ﹤0.01% 2534
2025
Q2 		– Sell
-3,677
Closed -$11.9K – 3033
2025
Q1 		$11.9K Sell
3,677
-22,389
-86% -$105K ﹤0.01% 2711
2024
Q4 		$145K Sell
26,066
-177
-0.7% -$1.39K ﹤0.01% 2366
2024
Q3 		$284K Sell
26,243
-2,853
-10% -$47.3K ﹤0.01% 2315
2024
Q2 		$611K Buy
29,096
+606
+2% +$15.2K ﹤0.01% 2001
2024
Q1 		$908K Buy
28,490
+3,197
+13% +$81.6K ﹤0.01% 1844
2023
Q4 		$512K Sell
25,293
-1,866
-7% -$24.6K ﹤0.01% 2197
2023
Q3 		$346K Sell
27,159
-8,437
-24% -$141K ﹤0.01% 2363
2023
Q2 		$643K Buy
35,596
+8,788
+33% +$162K ﹤0.01% 2170
2023
Q1 		$461K Buy
26,808
+14,828
+124% +$288K ﹤0.01% 2344
2022
Q4 		$266K Sell
11,980
-23,489
-66% -$363K ﹤0.01% 2563
2022
Q3 		$285K Sell
35,469
-614
-2% -$5.56K ﹤0.01% 2546
2022
Q2 		$252K Buy
36,083
+3,337
+10% +$32.4K ﹤0.01% 2617
2022
Q1 		$495K Sell
32,746
-2,868
-8% -$45K ﹤0.01% 2408
2021
Q4 		$781K Buy
35,614
+13,349
+60% +$327K ﹤0.01% 2300
2021
Q3 		$600K Buy
22,265
+8,707
+64% +$248K ﹤0.01% 2406
2021
Q2 		$326K Buy
13,558
+1,821
+16% +$55.7K ﹤0.01% 2867
2021
Q1 		$509K Buy
+11,737
New +$520K ﹤0.01% 2518

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

California State Teachers Retirement System (CalSTRS)'s FDMT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its 4D Molecular Therapeutics (FDMT) stake by 74% in Q2 2026, selling an estimated $17.6K and leaving 620 shares worth $8.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

California State Teachers Retirement System (CalSTRS) first reported a position in FDMT in Q1 2021 and has held it in 21 quarters since. The position peaked at $908K in Q1 2024. 158 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 620 shares of 4D Molecular Therapeutics worth $8.25K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,809 4D Molecular Therapeutics shares in Q2 2026, an estimated $17.6K.
  • 4D Molecular Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2365 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in 4D Molecular Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s 4D Molecular Therapeutics position peaked at $908K in Q1 2024.
  • 158 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.